title: Discontinued drugs in 2010: cardiovascular drugs.
abstract: This perspective is a paper discussing drugs dropped from clinical development in the previous years. Specifically, this paper focuses on 16 cardiovascular drugs discontinued in 2010 after reaching Phase I - III clinical trials. Information for this perspective is mainly derived from a search of Pharmaprojects.
authors.affiliation: Center for Instrumental Analysis, China Pharmaceutical University, Nanjing, Key Laboratory of Drug Quality Control & Pharmacovigilance, Ministry of Education, Jiangsu 210009, People's Republic of China. hpzhaojstar@126.com
authors.forename: Hong-ping
authors.initials: HP
authors.lastname: Zhao
authors.forename: Xu-song
authors.initials: XS
authors.lastname: Zhang
authors.forename: Bing-ren
authors.initials: BR
authors.lastname: Xiang
mesh_terms: D002317:Cardiovascular Agents / Q000009:adverse effects / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D055808:Drug Discovery; D015507:Drugs, Investigational / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D057051:Product Recalls and Withdrawals; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D002317:Cardiovascular Agents; D015507:Drugs, Investigational